1. Pink Sheet
  2. >>Compliance

ADHD Drugs: FDA Commissioner Blames Inappropriate Prescribing For Shortages

 
• By Sue Sutter

ADHD drug shortages may have resulted from industry reticence to fill DEA quotas, as well as a 'heavy element of professional responsibility' with off-label prescribing, Robert Califf told a House appropriations subcommittee.

ADHD drugs
ADHD drugs are in short supply, partly because of inappropriate prescribing, the FDA's Robert Califf said. • Source: Shutterstock

US Food and Drug Administration Commissioner Robert Califf is taking health care providers to task for off-label prescribing of stimulants, which has led to a shortage of approved treatments for attention deficit/hyperactivity disorder.

Constraints on the ADHD drug supply were among several drug-related issues that Califf discussed with the House Appropriations Subcommittee on Agriculture, Rural Development and the FDA during an

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Distribution/Supply Chain

More from Compliance